| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Jun 24 | SYRS Syros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 16,000 |
| 5 Jun 24 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.3 | 6,000 | 31.80 k | 6,000 |
| 31 May 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 18,838 | 0.00 | 34,262 |
| 5 Jan 24 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 15,424 | 0.00 | 15,424 |
| 5 Jan 24 | EXEL Exelixis | Option Common Stock | Grant | Acquire A | No | No | 23.24 | 30,848 | 716.91 k | 30,848 |
